Application 204730
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | FROVATRIPTAN SUCCINATE | FROVATRIPTAN SUCCINATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-694 | frovatriptan succinate | frovatriptan succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-694 | frovatriptan succinate | frovatriptan succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-694 | frovatriptan succinate | frovatriptan succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |